Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.67 |
| ▸ | CA9 | Q16790 | 4/20 | 0.67 |
| ▸ | CA1 | P00915 | 3/20 | 0.67 |
| ▸ | PPARG | P37231 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA3 | P07451 | 1/20 | 0.42 |
| ▸ | CA6 | P23280 | 1/20 | 0.42 |
| ▸ | CA5A | P35218 | 1/20 | 0.42 |
| ▸ | CA7 | P43166 | 1/20 | 0.42 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.42 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.41 |
| ▸ | TEAD4 | Q15561 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3887581 | 0.91 | HTT (0.58) | CA2CA9CA1PPARGACHE | |
| SCHEMBL3884706 | 0.88 | CA2 (0.59) | CA2CA9CA1PPARGACHE | |
| SCHEMBL3363890 | 0.87 | CA2 (0.53) | CA2CA9CA1PPARGACHE | |
| SCHEMBL20017110 | 0.86 | CA2 (0.57) | CA2CA9CA1PPARGACHE | |
| SCHEMBL27604161 | 0.84 | CA2 (0.55) | CA2CA9CA1PPARGACHE | |
| SCHEMBL17466421 | 0.83 | CA2 (0.53) | CA2CA9CA1PPARGACHE | |
| SCHEMBL3895027 | 0.83 | CA2 (0.53) | CA2CA9CA1PPARGACHE | |
| SCHEMBL17466353 | 0.83 | CA2 (0.53) | CA2CA9CA1PPARGACHE | |
| SCHEMBL28224975 | 0.82 | CA1 (0.48) | CA2CA9CA1PPARGGAA | |
| SCHEMBL168170 | 0.82 | CA2 (0.64) | CA2CA9CA1PPARGACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2302030-B1 | Reagents for lysis of bacterial cells | ROCHE DIAGNOSTICS GMBH (DE) | 2011-11-16 | — | — | EP | claimed |
| EP-0465730-B1 | Photographic infrared sensitized material containing a speed enhancing agent | AGFA GEVAERT NV (BE) | 1996-06-05 | — | — | EP | claimed |
| WO-1995020637-A2 | HYDROCARBON OIL-AQUEOUS FUEL AND ADDITIVE COMPOSITIONS | MEG S.N.C. DI SCOPELLITI SOFIA & C. (IT) | 1995-08-03 | — | — | WO | claimed |
| EP-0465730-A1 | Photographic infrared sensitized material containing a speed enhancing agent | AGFA-GEVAERT N.V. (BE) | 1992-01-15 | — | — | EP | claimed |
| US-12100809-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2024-09-24 | — | — | US | disclosed |
| CN-110088108-B | Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitors | 联合疗法公司 | 2024-06-14 | — | — | CN | disclosed |
| US-20230364093-A1 | PHARMACEUTICAL COMPOSITION CONTAINING PALBOCICLIB AND LETROZOLE | EGIS GYÓGYSZERGYÁR ZRT. (HU) | 2023-11-16 | — | — | US | disclosed |
| US-11672804-B1 | Pharmaceutical composition containing palbociclib and letrozole | EGIS GYÓGYSZERGYÁR ZRT. (HU) | 2023-06-13 | — | — | US | disclosed |
| US-20220149436-A1 | NON-AQUEOUS LIQUID ELECTROLYTE AND NON-AQUEOUS LIQUID ELECTROLYTE SECONDARY BATTERY | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-05-12 | — | — | US | disclosed |
| US-11283107-B2 | Non-aqueous liquid electrolyte and non-aqueous liquid electrolyte secondary battery | MITSUBISHI CHEMICAL CORPORATION (JP) | 2022-03-22 | — | — | US | disclosed |
| CN-112007052-A | Kidney-protecting probiotic composition | 上海泓商生物科技有限公司 | 2020-12-01 | — | — | CN | disclosed |
| CN-111032064-A | Methods for maintaining and improving renal function in patients with renal disease and receiving standard of care therapy | 基博生物技术公司 | 2020-04-17 | — | — | CN | disclosed |
| US-20030219673-A1 | Selected acid generating agents and their use in processes for imaging radiation-sensitive elements | FPC INC. | 2003-11-27 | — | — | US | disclosed |
| EP-0465730-B1 | Photographic infrared sensitized material containing a speed enhancing agent | AGFA GEVAERT NV (BE) | 1996-06-05 | — | — | EP | disclosed |
| WO-1995020637-A2 | HYDROCARBON OIL-AQUEOUS FUEL AND ADDITIVE COMPOSITIONS | MEG S.N.C. DI SCOPELLITI SOFIA & C. (IT) | 1995-08-03 | — | — | WO | disclosed |
| EP-0609571-A1 | Stilbene compounds as supersensitizers in infrared sensitive photographic materials | AGFA-GEVAERT N.V. (BE) | 1994-08-10 | — | — | EP | disclosed |
| US-5190854-A | Cyanine sensitizers and quinolone compounds | AGFA-GEVAERT, N.V. (BE) | 1993-03-02 | — | — | US | disclosed |
| US-5190854-A | Cyanine sensitizers and quinolone compounds | AGFA-GEVAERT, N.V. (BE) | 1993-03-02 | — | — | US | disclosed |
| EP-0465730-A1 | Photographic infrared sensitized material containing a speed enhancing agent | AGFA-GEVAERT N.V. (BE) | 1992-01-15 | — | — | EP | disclosed |
| EP-0465730-A1 | Photographic infrared sensitized material containing a speed enhancing agent | AGFA-GEVAERT N.V. (BE) | 1992-01-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11672804-B1 | Pharmaceutical composition containing palbociclib and letrozole | CDK4, BRCA1, CDK11B | CA2 3723/4885CA9 1906/4885CA1 4521/4885 |
| US-20230364093-A1 | PHARMACEUTICAL COMPOSITION CONTAINING PALBOCICLIB AND LETROZOLE | CDK4, BRCA1, CDK11B | CA2 3723/4885CA9 1906/4885CA1 4521/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.